The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Goldman, M. B.
* Articles by Janecek, H. M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Goldman, M. B.
* Articles by Janecek, H. M.

J Neuropsychiatry Clin Neurosci 1990; 2:429-431
Copyright © 1990 by American Neuropsychiatric Association

REGULAR ARTICLES

Adjunctive fluoxetine improves global function in chronic schizophrenia

MB Goldman and HM Janecek
Elgin Mental Health Center, Illinois.

Eight chronic schizophrenic inpatients received adjunctive fluoxetine (20 mg/day) for a mean of 10.6 weeks in an open clinical trial. Clinical state improved in all patients. Violent incidents decreased, while participation in programs and socialization increased.




Get information about faster international access.

Privacy Policy

Copyright © 1990 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org